Community voting is open to everyone. Members vote once per account, qualify for prizes, and see a members-only tally that is a cleaner signal.
Contract terms
Will Lantus (insulin glargine) WAC be between $2,000–$3,200/year by Dec 31, 2026? · v1 (current)
Market metadata
Market
insulin-glargine-wac-range-2000-3200-2026
Market ID
694558225cd285b7ccf3fb1c
Rules version
v1
Rules published
Dec 19, 2025, 01:50 PM
Opens
Dec 19, 2025, 01:50 PM
Locks
Dec 29, 2025, 01:50 PM
Resolve-by
Measurement
WAC per year
Price range
$2,000–$3,200
Outcomes
This is a price-range bucket. YES resolves if the price is $2,000–$3,200; otherwise the outcome is NO. If the market is voided, stakes are refunded.
Resolution rules
Resolves YES if US WAC annualized price for Lantus (insulin glargine) is within [$2,000, $3,200] as of Dec 31, 2026 (inclusive). Primary source: sponsor WAC/list price publication or a clearly cited WAC source. Otherwise NO.
Resolution procedure

Probiful admins resolve markets using the criteria above. If multiple sources disagree, admins follow the source hierarchy described in the resolution rules (if present).

Lock time: Dec 29, 2025, 01:50 PM. For “by date” markets, the phrase “on or before” is interpreted as inclusive of the calendar date shown in the contract.

If the market cannot be fairly resolved (e.g., no authoritative sources), it may be voided and stakes refunded.

Sources referenced
Accessed: Mar 26, 2026. This page is a snapshot of rules version v1.